Search

1023 Result(s)
Sort by

Zoonotic diseases things you should know

Zoonotic diseases things you should know

Zoonotic diseases can be transmitted between animals and humans. They are more common than you may think – and they are on the rise. Find out how this affects you.
Spesolimab Phase II data

Spesolimab Phase II data

New data published in NEJM shows spesolimab improved signs & symptoms of GPP flares
Expectations towards our business partners

Expectations towards our business partners

We utilize an extensive network of international suppliers for procuring raw materials, intermediates, packaging materials, technical components and services to deliver our innovative medications worldwide.
Our partners university of georgia

Our partners university of georgia

We're partnering with the University of Georgia to address unmet needs and find solutions to some of the biggest challenges in animal health.
Dan

Dan

People with Type 2 diabetes (T2D) have an increased risk of heart disease
Labor & Human Rights

Labor & Human Rights

Suppliers shall support and respect the protection of internationally proclaimed human rights.
Elke

Elke

People with Type 2 diabetes (T2D) have an increased risk of heart disease.
Isabel

Isabel

In this video, Isabel shares how watching her children and grandchildren grow up inspires her to take the necessary steps to manage her life with type 2 diabetes and heart disease.
Reinhold

Reinhold

People with type 2 diabetes have an increased risk of heart disease and this can have a profound impact on their everyday lives
Investment of 65 million euro in avian vaccines in France

Investment of 65 million euro in avian vaccines in France

Boehringer Ingelheim is set to invest almost €65 million in a high-tech building at its Lyon Portes-des-Alpes site in Saint-Priest, France (Rhône), to meet the growing demand worldwide for avian vaccines
Our partners Bioveta

Our partners Bioveta

Our partner Bioveta shares insights about the longstanding collaboration with Boehringer Ingelheim and the evolution of the partnership
Partnership-with-clicktherapeutics

Partnership-with-clicktherapeutics

Boehringer Ingelheim collaborates with Click Therapeutics on prescription-based digital therapeutic to potentially aid in the treatment of schizophrenia
Phase II trials for patients with bronchiectasis

Phase II trials for patients with bronchiectasis

Bronchiectasis is a chronically progressive pulmonary disease. Boehringer Ingelheim investigates a potential new treatment option in two Phase II trials.